DMM’s Holding Company Host Public Expose and Prepares for IPO to Drive Long-Term Growth and Expansion

The holding company of PT Deca Metric Medica (DMM), PT Medela Potentia Tbk (Medela Potentia), conducted a Public Expose and Due Diligence Meeting in Jakarta on Thursday, March 13, 2025. During the event, the company announced plans to launch its Initial Public Offering (IPO) on April 15, 2025.

In this IPO, Medela Potentia will offer 3.5 billion shares, representing 25% of the company’s issued and fully paid capital. During the bookbuilding period from March 11 to March 17, 2025, shares will be offered at a price range of IDR 180 to IDR 230 per share. Based on this price range, the company is projected to raise approximately IDR 805 billion.

President Director of Medela Potentia, Mr. Krestijanto Pandji, stated that the healthcare industry is poised for significant growth. “We are committed to investing in technology, infrastructure, and product innovation to support Indonesia’s expanding healthcare needs,” Mr. Krestijanto affirmed.

He further highlighted the high demand for medical devices in Indonesia. Medela Potentia supports the availability of medical equipment domestically through production at PT Deca Metric Medica and distribution via PT Djembatan Dua.

“Medela Potentia possesses end-to-end competencies. We provide services not only in major cities but across the entire Indonesian archipelago,” Mr. Krestijanto added.

The distribution of various healthcare products throughout Indonesia is managed by PT Anugrah Argon Medica (AAM). Additionally, Medela Potentia operates in Cambodia through its subsidiary Dynamic Argon Cambodia (DAC).

Director of Medela Potentia, Mr. Edbert Orotodan, noted that demand for medical devices in Indonesia has increased significantly following the COVID-19 pandemic. “During that period, the public sought not only medicines but also medical devices such as masks and other protective equipment,” he explained.

Meanwhile, Director Mr. Wimala Wijaya emphasized the critical role of technology adaptation in the healthcare industry. “Digitalization is an inevitable challenge. To grow, we must embrace digital transformation,” Mr. Wimala stated.

He also explained how GoApotik addresses the public’s need for easier access to healthcare products. GoApotik has recently obtained a license as an Electronic Pharmacy System Provider (PSEF).

Medela Potentia intends to utilize the proceeds from this IPO to support strategic plans for innovation and global expansion. This initiative aims to strengthen the company’s position as a leading provider of high-quality healthcare services in Indonesia and the Southeast Asian region.

With over four decades of experience in expanding access to quality healthcare, Medela Potentia and its subsidiaries have evolved from a healthcare service and product provider into an integrated distribution platform offering a wide range of health products and medical devices, ensuring broad access to healthcare services across Indonesia.

This commitment aligns with the company’s vision to become a trusted global healthcare services group, delivering significant value to customers and business partners. To realize this vision, Medela Potentia focuses on providing a strong and extensive supply chain and distribution network, implementing cutting-edge systems and technologies, maintaining the highest quality standards for all products, and developing top-tier talent.